Page last updated: 2024-11-04

succinylcholine and Myotonic Dystrophy

succinylcholine has been researched along with Myotonic Dystrophy in 14 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research Excerpts

ExcerptRelevanceReference
"A 28-year-old woman died of irreversible ventricular fibrillation after administration of succinylcholine because of post partum curettage."3.69[Fatal arrhythmia following administration of suxamethonium in a postpartum woman subsequently found to have dystrophia myotonica]. ( Rozendaal, FW; Rupreht, J, 1996)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19906 (42.86)18.7374
1990's3 (21.43)18.2507
2000's4 (28.57)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weingarten, TN1
Hofer, RE1
Milone, M1
Sprung, J1
Casado Merodio, AI1
Pascual Bellosta, A1
Arauzo Pérez, P1
Gómez Muñoz, C1
Ortega Lucea, S1
Pérez Barrero, P1
ORNDAHL, G1
STENBERG, K1
Rozendaal, FW1
Rupreht, J1
Wintzen, AR1
Tomlinson, S1
Macartney, I1
Lam, S1
Norman, B1
Kannan, S1
Kaufman, L1
Brown, BR1
Walson, PD1
Taussig, LM1
Morse, HR1
Weiss, EA1
Highsmith, JP1
Moulds, RF1
Denborough, MA1
Dalal, FY1
Bennett, EJ1
Raj, PP1
Lee, DG1
Britt, BA1
Locher, WG1
Kalow, W1

Other Studies

14 other studies available for succinylcholine and Myotonic Dystrophy

ArticleYear
Anesthesia and myotonic dystrophy type 2: a case series.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2010, Volume: 57, Issue:3

    Topics: Adult; Anesthesia; Anesthetics, Inhalation; Cholinesterase Inhibitors; Female; Humans; Intraoperativ

2010
[Locoregional anesthesia and sedation with remifentanil in a case of Steinert disease].
    Revista espanola de anestesiologia y reanimacion, 2003, Volume: 50, Issue:2

    Topics: Brachial Plexus; Cholinesterase Inhibitors; Colles' Fracture; Contraindications; Female; Fracture Fi

2003
Myotonic human musculature: stimulation with depolarizing agents. Mechanical registration of the effects of succinyldicholine, succinylmonocholine and decamethonium.
    Acta medica Scandinavica. Supplementum, 1962, Volume: 389

    Topics: Amyotrophic Lateral Sclerosis; Decamethonium Compounds; Humans; Muscular Atrophy; Muscular Dystrophi

1962
[Fatal arrhythmia following administration of suxamethonium in a postpartum woman subsequently found to have dystrophia myotonica].
    Nederlands tijdschrift voor geneeskunde, 1996, Jun-22, Volume: 140, Issue:25

    Topics: Adult; Fatal Outcome; Female; Humans; Myotonic Dystrophy; Neuromuscular Depolarizing Agents; Pregnan

1996
[Fatal arrhythmia following administration of suxamethonium to a postpartum women who subsequently was found to have dystrophia myotonica].
    Nederlands tijdschrift voor geneeskunde, 1996, Aug-31, Volume: 140, Issue:35

    Topics: Adult; Anesthesia; Female; Humans; Myotonic Dystrophy; Neuromuscular Depolarizing Agents; Succinylch

1996
Dystrophica myotonia and suxamethonium.
    Anaesthesia, 1999, Volume: 54, Issue:12

    Topics: Contraindications; Humans; Male; Middle Aged; Myotonic Dystrophy; Neuromuscular Depolarizing Agents;

1999
Dystrophia myotonica and succinylcholine.
    Anaesthesia, 2000, Volume: 55, Issue:5

    Topics: Contraindications; Humans; Myotonic Dystrophy; Neuromuscular Depolarizing Agents; Succinylcholine

2000
Dystrophia myotonica and succinylcholine.
    Anaesthesia, 2000, Volume: 55, Issue:5

    Topics: Contraindications; Humans; Myotonic Dystrophy; Neuromuscular Depolarizing Agents; Succinylcholine

2000
Dystrophia myotonica and succinylcholine.
    Anaesthesia, 2000, Volume: 55, Issue:9

    Topics: Contraindications; Humans; Intubation, Intratracheal; Myotonic Dystrophy; Neuromuscular Depolarizing

2000
Congenital metabolic diseases of pediatric patients: anesthetic implications.
    Anesthesiology, 1975, Volume: 43, Issue:2

    Topics: Acidosis; Anesthesia; Child; Cystic Fibrosis; Dysautonomia, Familial; Glycogen Storage Disease Type

1975
Endoscopy in a patient with myotonic dystrophy.
    Ear, nose, & throat journal, 1985, Volume: 64, Issue:10

    Topics: Anesthesia, Intravenous; Deglutition Disorders; Esophagoscopy; Female; Humans; Middle Aged; Myotonic

1985
Letter: Myopathies and malignant hyperpyrexia.
    British medical journal, 1974, Aug-24, Volume: 3, Issue:5929

    Topics: Caffeine; Calcium; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscles;

1974
Dystrophia myotonica: a multisystem disease.
    Canadian Anaesthetists' Society journal, 1972, Volume: 19, Issue:4

    Topics: Anesthesia; Atropine; Cholinesterases; Electromyography; Halothane; Humans; Male; Melanoma; Middle A

1972
Hereditary aspects of malignant hyperthermia.
    Canadian Anaesthetists' Society journal, 1969, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Age Factors; Anesthesia, Inhalation; Child; Child, Preschool; Female; Fever; Gene

1969